Five miRNAs as novel diagnostic biomarker candidates for primary nasopharyngeal carcinoma

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 18, 2014, Pages 7575-7581

  Tang, Jin Feng ^a   Yu, Zhong Hua ^a   Liu, Tie ^b   Lin, Zi Ying ^a   Wang, Ya Hong ^a   Yang, La Wei ^a   He, Hui Juan ^a   Cao, Jun ^a   Huang, Hai Li ^a   Liu, Gang ^a  

^a GUANGDONG MEDICAL UNIVERSITY   (China)

^b MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

Biomarkers; miRNAs; Nasopharyngeal carcinomas; QRT PCR

Indexed keywords

MICRORNA; TUMOR MARKER;

ADULT; CANCER STAGING; CASE CONTROL STUDY; COMPARATIVE STUDY; ENZYME IMMUNOASSAY; FEMALE; FOLLOW UP; GENE EXPRESSION PROFILING; GENETICS; HUMAN; MALE; METABOLISM; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NASOPHARYNX; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION PROFILING; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MICRORNAS; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NASOPHARYNX; NEOPLASM STAGING; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; ROC CURVE; TUMOR MARKERS, BIOLOGICAL;

EID: 84908052398     PISSN: 15137368     EISSN: None     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.18.7575     Document Type: Article

References (41)

1. Abbasi A N, Zahid S, Bhurgri Y, et al (2011). Nasopharyngeal carcinoma-an update of treatment and acute radiation induced reactions from a tertiary-care hospital in Pakistan. Asian Pac J Cancer Prev, 12, 735-8.
2. Cao P, Zhou L, Zhang J, et al (2013). Comprehensive expression profiling of microRNAs in laryngeal squamous cell carcinoma. Head Neck, 35, 720-8.
3. Chen H C, Chen G H, Chen Y H, et al (2009). MicroRNA deregulation and pathway alterations in nasopharyngeal carcinoma. Br J Cancer, 100, 1002-11.
4. Fu X, Tian J, Zhang L, et al (2012). Involvement of microRNA-93, a new regulator of PTEN/Akt signaling pathway, in regulation of chemotherapeutic drug cisplatin chemosensitivity in ovarian cancer cells. FEBS Lett, 586, 1279-86.
5. Guo X-G, Xia Y (2013). The interleukin-18 promoter-607C> A polymorphism contributes to nasopharyngeal carcinoma Risk: Evidence from a Meta-analysis Including 1, 886 Subjects. Asian Pac J Cancer Prev, 14, 7577-81.
6. Iizasa H, Wulff BE, Alla NR, et al (2010). Editing of Epstein-Barr virus-encoded BART6 microRNAs controls their dicer targeting and consequently affects viral latency. J Biol Chem, 285, 33358-70.
7. Iorio MV, Croce CM (2012). microRNA involvement in human cancer. Carcinogenesis, 33, 1126-33.
8. Jiang M, Zhang P, Hu G, et al (2013). Relative expressions of miR-205-5p, miR-205-3p, and miR-21 in tissues and serum of non-small cell lung cancer patients. Mol Cell Biochem, 383, 67-75.
9. Kozubek J, Ma Z, Fleming E, et al (2013). In-depth characterization of microRNA transcriptome in melanoma. PLoS One, 8, 72699.
10. Larne O, Martens-Uzunova E, Hagman Z, et al (2013). miQ-a novel microRNA based diagnostic and prognostic tool for prostate cancer. Int J Cancer, 132, 2867-75.
11. Lauvrak S U, Munthe E, Kresse S H, et al (2013). Functional characterisation of osteosarcoma cell lines and identification of mRNAs and miRNAs associated with aggressive cancer phenotypes. Br J Cancer, 109, 2228-36.
12. Lebanony D, Benjamin H, Gilad S, et al (2009). Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma. J Clin Oncol, 27, 2030-7.
13. Lee N, Xia P, Quivey J M, et al (2002). Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. Int J Radiat Oncol Biol Phys, 53, 12-22.
14. Li MY, Liu JQ, Chen DP, et al (2014). Glycididazole sodium combined with radiochemotherapy for locally advanced nasopharyngeal carcinoma. Asian Pac J Cancer Prev, 15, 2641.
15. Li T, Chen J X, Fu X P, et al (2011). microRNA expression profiling of nasopharyngeal carcinoma. Oncol Rep, 25, 1353-63.
16. Lin JC, Chiang CF, Wang SW, et al (2014). Significance of Expression of Human METCAM/MUC18 in Nasopharyngeal Carcinomas and Metastatic Lesions. Asian Pac J Cancer Prev, 15, 245-52.
17. Liu N, Chen N Y, Cui R X, et al (2012). Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis. Lancet Oncol, 13, 633-641.
18. Liu N, Cui R X, Sun Y, et al (2014). A four-miRNA signature identified from genome-wide serum miRNA profiling predicts survival in patients with nasopharyngeal carcinoma. Int J Cancer, 134, 1359-68.
19. Liu N, Tang L L, Sun Y, et al (2013a). MiR-29c suppresses invasion and metastasis by targeting TIAM1 in nasopharyngeal carcinoma. Cancer Lett, 329, 181-8.
20. Liu X, Luo H N, Tian W D, et al (2013b). Diagnostic and prognostic value of plasma microRNA deregulation in nasopharyngeal carcinoma. Cancer Biol Ther, 14.
21. Lo A K, Dawson C W, Jin D Y, et al (2012). The pathological roles of BART miRNAs in nasopharyngeal carcinoma. J Pathol, 227, 392-03.
22. Long J, Wang Y, Wang W, et al (2010). Identification of microRNA-93 as a novel regulator of vascular endothelial growth factor in hyperglycemic conditions. J Biological Chemis, 285, 23457-65.
23. Lu J, Getz G, Miska E A, et al (2005). MicroRNA expression profiles classify human cancers. Nature, 435, 834-8.
24. Luo W R, Gao F, Li S Y, et al (2012). Tumour budding and the expression of cancer stem cell marker aldehyde dehydrogenase 1 in nasopharyngeal carcinoma. Histopathology, 61, 1072-81.
25. Ma F, Zhang J, Zhong L, et al (2014). Upregulated microRNA-301a in breast cancer promotes tumor metastasis by targeting PTEN and activating Wnt/beta-catenin signaling. Gene, 535, 191-7.
26. Marquitz A R, Raab-Traub N (2012). The role of miRNAs and EBV BARTs in NPC. Semin Cancer Biol, 22, 166-72.
27. Qiu J, Cosmopoulos K, Pegtel M, et al (2011). A novel persistence associated EBV miRNA expression profile is disrupted in neoplasia. PLoS Pathog, 7, 1002193.
28. Raab-Traub N, Flynn K, Pearson G, et al (1987). The differentiated form of nasopharyngeal carcinoma contains Epstein-Barr virus DNA. Int J Cancer, 39, 25-29.
29. Sarver A L, Li L, Subramanian S (2010). MicroRNA miR-183 functions as an oncogene by targeting the transcription factor EGR1 and promoting tumor cell migration. Cancer Res, 70, 9570-80.
30. Schetter A J, Harris C C (2011). Alterations of microRNAs contribute to colon carcinogenesis. Semin Oncol, 38, 734-72.
31. Shanmugaratnam K, 1991, Histological typing of tumours of the upper respiratory tract and ear. World Health Organization International Histological Classification of Tumours. Springer-Verlag, Berlin, p. 32-34 pp.
32. Sun XJ, Liu H, Zhang P, et al (2013). miR-10b promotes migration and invasion in nasopharyngeal carcinoma cells. Asian Pac J Cancer Prev, 14, 5533-37.
33. Tsuchiyama K, Ito H, Taga M, et al (2013). Expression of microRNAs associated with Gleason grading system in prostate cancer: miR-182-5p is a useful marker for high grade prostate cancer. Prostate, 73, 827-34.
34. Wolf H, Zur Hausen H, Klein G, et al (1975). Attempts to detect virus-specific DNA sequences in human tumors. III. Epstein-Barr viral DNA in non-lymphoid nasopharyngeal carcinoma cells. Med Microbiol Immunol, 161, 15-21.
35. Xi Y, Nakajima G, Gavin E, et al (2007). Systematic analysis of microRNA expression of RNA extracted from fresh frozen and formalin-fixed paraffin-embedded samples. RNA, 13, 1668-74.
36. Xiao Z G, Deng Z S, Zhang Y D, et al (2013). Clinical significance of microRNA-93 downregulation in human colon cancer. Eur J Gastroenterol Hepatol, 25, 296-01.
37. Xie L, Yang Z, Li G, et al (2013). Genome-wide identification of bone metastasis-related microRNAs in lung adenocarcinoma by high-throughput sequencing. PLoS One, 8, 61212.
38. Yang H J, Huang T J, Yang C F, et al (2013). Comprehensive profiling of Epstein-Barr virus-encoded miRNA species associated with specific latency types in tumor cells. Virol J, 10, 314.
39. Yang I P, Tsai H L, Hou M F, et al (2012). MicroRNA-93 inhibits tumor growth and early relapse of human colorectal cancer by affecting genes involved in the cell cycle. Carcinogenesis, 33, 1522-30.
40. Zheng G, Wang H, Zhang X, et al (2013). Identification and validation of reference genes for qPCR detection of serum microRNAs in colorectal adenocarcinoma patients. PLoS One, 8, 83025.
41. Zhi F, Cao X, Xie X, et al (2013). Identification of circulating MicroRNAs as potential biomarkers for detecting acute myeloid leukemia. PloS one, 8, 56718.